Company / EPS (Basic)
Revvity EPS (Basic) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$5.56
FY2025
5-year range
$2.06 / $8.12
FY2021-FY2025
Trend
+23.3%
vs FY2024
Sector context
#29 of 160
Health Care
What the data says
Revvity's eps (basic) of $5.56 is higher than 82% of companies in the Health Care sector (FY2025). EPS (Basic) has fluctuated over the past 10 years, ranging from $1.40 in FY2016 to $8.12 in FY2023.
Based on SEC 10-K filings.
5.56 in FY2025 with a 5-year CAGR of +20.9%. Top quartile in the Health Care sector.
Declined from $8.12 to $5.56 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -5.2%
- 5-Year CAGR
- +20.9%
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 160This company $5.56 Sector average $1.57
▼
+253.2% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) increased 23.3% year-over-year.
- Ranks #29 out of 160 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2023.
- Lowest eps (basic) in the period was in FY2016.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.56 | +23.3% |
| FY2024 | $4.51 | -44.5% |
| FY2023 | $8.12 | +24.5% |
| FY2022 | $6.52 | +216.5% |
| FY2021 | $2.06 | -4.2% |
| FY2020 | $2.15 | -19.5% |
| FY2019 | $2.67 | +24.8% |
| FY2018 | $2.14 | +13.2% |
| FY2017 | $1.89 | +35.0% |
| FY2016 | $1.40 | -6.0% |
As of FY2025 · SEC 10-K · Updated Mar 14, 2026